RWM
CRL icon

Rialto Wealth Management’s Charles River Laboratories CRL Stock Holding History

Rialto Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.99K Buy
22
+7
+47% +$1.25K ﹤0.01% 746
2026
Q1 		$2.59K Buy
15
+2
+15% +$371 ﹤0.01% 775
2025
Q4 		$2.59K Buy
13
+2
+18% +$363 ﹤0.01% 654
2025
Q3 		$1.72K Hold
11
– – ﹤0.01% 710
2025
Q2 		$1.67K Buy
+11
New +$1.47K ﹤0.01% 662

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Rialto Wealth Management's CRL Position: Q2 2026 in Review

Rialto Wealth Management increased its Charles River Laboratories (CRL) stake by 47% in Q2 2026, buying an estimated $1.25K and bringing the position to 22 shares worth $4.99K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

Rialto Wealth Management first reported a position in CRL in Q2 2025 and has held it in 5 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Rialto Wealth Management held 22 shares of Charles River Laboratories worth $4.99K as of Q2 2026.
  • Rialto Wealth Management bought 7 Charles River Laboratories shares in Q2 2026, an estimated $1.25K.
  • Charles River Laboratories made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #746 holding.
  • Rialto Wealth Management first reported a position in Charles River Laboratories in Q2 2025 and has held it in 5 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.